Biopharma: Advance your Lab with the Launch of Next-Gen LC-Mass Detection
Molecules are getting more complex and so are the challenges. In fast paced environments like research, development or manufacture delivering the right information at the right time can be the difference between success or failure. Learn how Next Generation LC-Mass Detection will revolutionize your mass confirmation and purification workflows so that you can efficiently gain more meaningful information from molecules large and small.
- Unparalleled performance
- User-friendly intelligence
- Unmatched sensitivity
- Widest mass range
- Stackable eco-friendly footprint
Listen to how expert level high quality data is now accessible to all skill levels through system intelligence that drives productivity giving you peace of mind to keep up with deliverables whatever you stage of research or development. Say hello to effortless integration of state-of-the-art mass detection with best-in-class Infinity III LC separation with InfinityLab Assist, and OpenLab CDS for cost efficient streamlined mass confirmation and mass based fraction collection solutions that ensure confidence in high-quality outcomes to keep your programs moving.
Presenter: Patrick Batoon (Agilent)
Patrick holds a PhD in Analytical and Physical Chemistry, with a background in Mass Spectrometry/Ion Chemistry. He started his career at Agilent in 2016 and works as a R&D Manager for LC/MS Quadrupole product development.
Presenter: Ian Edwards (Strategic Marketing Product Manager (SQ/TQ), Agilent)
Ian holds a Ph.D. from the Centre for Proteome Research at the University of Liverpool. He has spent time as a pre- and post-sales MS applications specialist focused on MS imaging and proteomics, as a field marketing manager for -omics, and as a global pharmaceutical marketing manager. Currently Ian manages the strategic product marketing for LC/MS SQ and LC/MS Triple Quadrupole product portfolios at Agilent.
